A Study to Investigate the Effects of DSP-6952 on the QT/QTc in Healthy Male and Female Volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223729

Enrollment

Registered

2017-11-22

Start date

2017-05-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

investigational material(s) Generic name etc : DSP-6952 INN of investigational material : minesapride Therapeutic category code : 2-- Agents affecting individual organs Dosage and Administration for I

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion Criteria Healthy subjects etc.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Subjects with any history of diseases that might be unsuitable for participation in the clinical study etc.

Design outcomes

Primary

Measure	Time frame
safety pharmacokinetics QT/QTc interval, Pharmacokinetics and Safety	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026